Drug-maker row escalates as Serono ignores court order
Article Abstract:
The article discusses how even though Biogen Inc. has obtained a Swiss court order preventing Serono AG from claiming superior effectiveness for its Rebif drug for multiple sclerosis, Serono gave a presentation anyway at a scientific conference in London.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Novartis drug gets EU approval
Article Abstract:
The European Union has approved Novartis AG's anti-diabetes drug Galvus, a DPP-4 inhibitor for treating Type 2 diabetes. However, the drug faces a delay in the US, as the Food and Drug Administration has requested more clinical reports.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Medicines Co. Gets U.S. FDA Approval For Anticlot Drug
Article Abstract:
The U.S. Food and Drug Administration has approved Angiomax, a new anticlotting drug which is manufactured by Medicines Co. Cambridge, Mass.-based Medicines obtained the rights for the drug from Cambridge, Mass.-based Biogen Inc.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Comverse reduces its profit estimates for quarter, year. Cendant agrees to buy Avis for up to $1 billion. Gore asks for patience, challenges certification
- Abstracts: AstraZeneca gets close to end of auction of unit. Novartis AG emerges as suitor for Monsanto. Abbott Will Acquire BASF's Knoll Unit
- Abstracts: Ingram Micro shares fall 31% as CEO says he'll quit. In electronics, U.S. companies seize momentum from Japan
- Abstracts: Red Herring Plans Its Second Round Of Staff Reductions. Dow Jones to cut newspaper jobs in Europe. Red Herring to lay off staff